$25.68
-0.80 (-3.02%)
As of May 8, 9:31 PM ET ·
Analyst Consensus
Hold
35
Analysts
Very High
Coverage
Buy 15 43%
Hold 17 49%
Sell 3 9%
Price Target
Analyst Price Target +32.0% upside
Low Target $24.03
Average Target $33.90
High Target $39.81
Current Price $25.68
Current
$25.68
Target
$33.90
$24.03 $33.90 avg $39.81
Scenario Analysis
Bear Case
$24.03
-6.4%
Low target
Base Case
$33.90
+32.0%
Avg target
Bull Case
$39.81
+55.0%
High target
Risk/Reward
8.6x
Highly favorable
Price in Context
52-Week High
$28.75
-10.7% from high
52-Week Low
$21.97
+16.9% from low
50-Day SMA
$25.92
-0.9% vs SMA
200-Day SMA
$24.89
+3.2% vs SMA
RSI (14)
57.0
Neutral
Target vs 52W High
$33.90
+17.9% vs high
Peer Consensus — Pharmaceuticals
Stock Consensus Analysts Buy % Target Upside
RDY
Dr. Reddy's Laboratories
Hold 45 51% +0.0%
LLY
Eli Lilly and Co.
Strong Buy 39 77% $1,330.33 +40.3%
JNJ
Johnson & Johnson
Buy 32 63% $299.55 +35.3%
MRK
Merck & Co. Inc.
Buy 35 69% $159.27 +43.0%
PFE
Pfizer Inc.
Hold 35 43% $33.90 +32.0%
BMY
Bristol-Myers Squibb Co
Hold 36 42% $174.50 +210.7%
ZTS
Zoetis Inc
Buy 25 60% $209.87 +153.4%
RPRX
Royalty Pharma Plc- Cl A
Strong Buy 16 88% $36.26 -28.6%